| Name | 5-[2-ethoxy-5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one |
|---|---|
| Synonyms |
5-[2-Ethoxy-5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]phenyl]-1,6-dihydro-1-Methyl-3-propyl-7H-pyrazolo[4,3-d]pyriMidin-7-one
Hydroxyhomosildenafil, Sildenafil analog Lodenafil Hydroxyhomosildenafil in Methanol Lodenafil (Hydroxyhomosildenafil) 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl hydroxyhomosildenafil Hydroxyhomosildenafil 5-(2-Ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one (Sildenafil Impurity) Lodenafil, 10 mM in DMSO Hydroxyhomosildenafil Solution, 100μg/mL 5-(2-Ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one inhibit,Phosphodiesterase (PDE),Lodenafil,Inhibitor |
| Description | Lodenafil is a potent phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED), with less oral bioavailability than Lodenafil carbonate[1]. |
|---|---|
| Related Catalog | |
| Target |
PDE5 |
| References |
| Density | 1.42g/cm3 |
|---|---|
| Boiling Point | 730.6ºC at 760 mmHg |
| Melting Point | 183-185 °C |
| Molecular Formula | C23H32N6O5S |
| Molecular Weight | 504.60200 |
| Flash Point | 395.7ºC |
| Exact Mass | 504.21500 |
| PSA | 142.03000 |
| LogP | 1.93000 |
| Vapour Pressure | 2.08E-22mmHg at 25°C |
| Index of Refraction | 1.667 |
| Hazard Codes | Xi |
|---|
|
~%
139755-85-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 51, # 9 p. 2807 - 2815 |
|
~%
139755-85-4 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 6, # 15 p. 1819 - 1824 |
|
~%
139755-85-4 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 6, # 15 p. 1819 - 1824 |
|
~%
139755-85-4 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 6, # 15 p. 1819 - 1824 |
|
~%
139755-85-4 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 6, # 15 p. 1819 - 1824 |
| Precursor 6 | |
|---|---|
| DownStream 0 | |